In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

DelMar Pharmaceuticals Inc. Trade Record

NASDAQ:DMPI DelMar Pharmaceuticals Inc stock gains 6.94% Exit Jan 10, 2019 a Trade Record by priceseries

Trade Chart
Trade Chart DMPI Jan 4, 2019, priceSeries
About DelMar Pharmaceuticals Inc

DelMar Pharmaceuticals, Inc., a clinical stage company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients who have failed to respond to modern therapy. Its product candidate includes VAL-083, a small-molecule chemotherapeutic agent, which is in Phase I/II study to evaluate the safety, tolerability, pharmacokinetics, and anti-cancer activity in patients with glioblastoma multiforme, a form of brain cancer. The company has a strategic collaboration with Guangxi Wuzhou Pharmaceutical Company for the manufacture and sale of VAL-083 in China; and collaboration with the University of Texas MD Anderson Cancer Center. DelMar Pharmaceuticals, Inc. was founded in 2009 and is headquartered in Vancouver, Canada.

Trade Information
Trade Type
Entry Date
Jan 4, 2019
Entry Price
Sell Date
Jan 10, 2019
Sell Price
Net Gain
Hold Time
4 Trading Days